Navigation Links
Inova Labs Receives CE Mark Approval for the LifeChoice® Portable Oxygen Concentrator System
Date:12/1/2011

AUSTIN, Texas, Dec. 1, 2011 /PRNewswire/ -- Inova Labs, a privately held medical device company focused on developing innovative products for the Chronic Obstructive Pulmonary Disease (COPD) Market, announced today that it has received CE Mark approval to begin marketing the LifeChoice® Portable Oxygen Concentrator System in Europe.

"This is a major milestone for our Company and for COPD patients who are on Long Term Oxygen Therapy," said John Rush, CEO of Inova Labs.  "The LifeChoice® technology allows patients to continue to live their daily lives with minimal disruption despite the advanced stage of their COPD disease."   

The Company is currently in discussions with potential partners in Europe and expects to begin marketing the LifeChoice® Technology in the region in early 2012.  

About Inova Labs

Inova Labs is an Austin, Texas based medical device company which develops and commercializes innovative products for the COPD market.  The company is currently marketing the LifeChoice® Portable Oxygen Concentrator System, which is the lightest and smallest oxygen concentrator on the market with FDA approval for continuous use by patients.   LifeChoice® delivers oxygen to the COPD patient using a proprietary "Pulse Wave" technology, which insures that the patient receives maximum benefit from the oxygen produced.  LifeChoice® also offers "Auto Mode" technology which enables the patient to automatically receive the prescribed oxygen dose during periods of activity as well as sleep.  The product is approved by FAA for air travel and is manufactured under strict ISO certification guidelines.

For further information Contact:

John Rush, President and CEO 

  Tel: 512-617-1700

 

 


'/>"/>
SOURCE Inova Labs
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sinovac to Present at 23rd Annual Piper Jaffray Health Care Conference and HK/China Mini Conference 2011 (Healthcare)
2. /C O R R E C T I O N -- Sinovac Biotech Ltd./
3. Sinovac Reports Unaudited Third Quarter 2011 Financial Results
4. Inova Labs Announces Launch of the LifeChoice Portable Oxygen Concentrator With Auto Mode Technology
5. Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
6. Inova Labs Closes on $17.5M Series B Financing
7. Sinovac to Host Conference Call to Report Third Quarter 2011 Unaudited Financial Results
8. Sinovac Reports Unaudited Second Quarter 2011 Financial Results
9. Sinovac Announces Management Changes
10. Sinovac Holds 2011 Annual Shareholders Meeting
11. Sinovac Appoints Kenneth Lee to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... North America , ... The global market is expected to reach USD 20,190.1 Million by ... of 10.2%. --> North America , ... MarketsandMarkets, The global market is expected to reach USD 20,190.1 Million ... CAGR of 10.2%. --> According to a new market ...
(Date:2/11/2016)... , February 11, 2016 ... Market Report 2016 research report provides information on ... development status with crucial statistical data and information ... http://www.deepresearchreports.com/142870.html . --> Complete report on ... companies and supported with 296 tables and figures ...
(Date:2/10/2016)... , Feb. 11, 2016  QT Vascular Ltd., together ... and together with its subsidiaries, the "Group"), is ... litigation with AngioScore, Inc. ("ÄngioScore") (now owned by ... the United States Court ... Circuit") reversed an earlier district court order (the ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... ... As part of their 2015 end of year funding strategy, Colleen’s ... gifted $10,000 to University of Chicago to support ovarian cancer research being conducted by ... honored to support a promising young investigator from Dr. Lengyel’s lab at the University ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... the World Molecular Imaging Congress (WMIC), will be held in New York City, ... is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals ...
(Date:2/10/2016)... ... 2016 , ... Early this week, Team Iconic at J. Walter Thompson and ... the first global confectionery brand sourced from 100% sustainable cocoa. , The Nestlé Cocoa ... product, through activities that focus on better farming, better lives and better cocoa. In ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... offering education, research and medical media, has launched Contagion® , a ... diseases. , As the all-inclusive resource for infectious disease information, Contagion features ...
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO ... new 2.0 version at the International Roofing Expo in Orlando, Florida on February ... world's most advanced weather technology in the hands of consumers, roofing contractors, manufacturers ...
Breaking Medicine News(10 mins):